ID: ALA5268622

Max Phase: Preclinical

Molecular Formula: C13H11NO3

Molecular Weight: 229.24

Associated Items:

Representations

Canonical SMILES:  Nc1ccc(Oc2ccccc2C(=O)O)cc1

Standard InChI:  InChI=1S/C13H11NO3/c14-9-5-7-10(8-6-9)17-12-4-2-1-3-11(12)13(15)16/h1-8H,14H2,(H,15,16)

Standard InChI Key:  QHUNNXCUJKOGMN-UHFFFAOYSA-N

Associated Targets(Human)

C-type lectin domain family 4 member M 115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 229.24Molecular Weight (Monoisotopic): 229.0739AlogP: 2.76#Rotatable Bonds: 3
Polar Surface Area: 72.55Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.38CX Basic pKa: 4.37CX LogP: 1.38CX LogD: -1.02
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.79Np Likeness Score: -0.30

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source